Toby Eyre: Big news in CLL

Toby Eyre, CLL specialist at Oxford University Hospitals, announced on X/Twitter:

“Big news in CLL. Pirtobrutinib now FDA-approved in patients who have received a prior cov BTKi and BCL2i following results of the BRUIN trial. Jaypirca (pirtobrutinib) now Approved by U.S. FDA for the Treatment of Adult Patients with CLL.”

For the article click here.
Source: Toby Eyre/X